Eli Lilly Stocks Rise 3.4% With Higher Sales but Lower EPS Guidance
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report is about the broad US market.
Directly affected
- LLY Eli Lilly+20.6% 30d
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF+0.1% 30d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- QQQ Invesco QQQ-10.3% 30d
Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Eli Lilly and belongs to, so it often moves with news about it.
- JNJ Johnson & Johnson+0.5% 30d
Johnson & Johnson is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+8.9% 30d
AbbVie is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+4.6% 17d
Merck is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+7.7% 30d
Abbott Laboratories is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- PFE Pfizer+9.0% 30d
Pfizer is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LLY | -9.71% | -8.92% | base | +0.15% | — | after close | after close |
| DIA | +1.17% | +1.48% | base | +0.44% | -0.16% | after close | after close |
| QQQ | +3.12% | +5.08% | base | -1.30% | -0.87% | after close | after close |
| XLV | -3.03% | -2.77% | base | -0.14% | -0.16% | after close | after close |
| JNJ | -2.53% | -0.72% | base | -0.98% | — | after close | after close |
| ABBV | -2.71% | -2.90% | base | -2.03% | — | after close | after close |
| MRK | -5.94% | -5.65% | base | -0.74% | — | after close | after close |
| ABT | -1.26% | -3.36% | base | +3.81% | +3.15% | after close | after close |
| PFE | -2.33% | -3.34% | base | +0.69% | — | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Eli Lilly Stocks Rise 3.4% With Higher Sales but Lower EPS Guidance Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | -2.03% | final price |
| ABBV | three days earlier | -2.90% | final price |
| ABBV | five days earlier | -2.71% | final price |
| ABT | that day | +3.81% | final price |
| ABT | the next day | +3.15% | still updating |
| ABT | three days earlier | -3.36% | final price |
| ABT | five days earlier | -1.26% | final price |
| DIA | that day | +0.44% | final price |
| DIA | the next day | -0.16% | still updating |
| DIA | three days earlier | +1.48% | final price |
| DIA | five days earlier | +1.17% | final price |
| JNJ | that day | -0.98% | final price |
| JNJ | three days earlier | -0.72% | final price |
| JNJ | five days earlier | -2.53% | final price |
| LLY | that day | +0.15% | final price |
| LLY | three days earlier | -8.92% | final price |
| LLY | five days earlier | -9.71% | final price |
| MRK | that day | -0.74% | final price |
| MRK | three days earlier | -5.65% | final price |
| MRK | five days earlier | -5.94% | final price |
| PFE | that day | +0.69% | final price |
| PFE | three days earlier | -3.34% | final price |
| PFE | five days earlier | -2.33% | final price |
| QQQ | that day | -1.30% | final price |
| QQQ | the next day | -0.87% | still updating |
| QQQ | three days earlier | +5.08% | final price |
| QQQ | five days earlier | +3.12% | final price |
| XLV | that day | -0.14% | final price |
| XLV | the next day | -0.16% | still updating |
| XLV | three days earlier | -2.77% | final price |
| XLV | five days earlier | -3.03% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 30 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 52 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 46 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 36 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 72 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 28 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 42 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Abbott Laboratories (ABT), worth $1,001 - $15,000 on 17 Sep 2026. That is 43 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100Price not final
“Eli Lilly Stocks Rise 3.4% With Higher Sales but Lower EPS Guidance” scores 12 out of 100. The score uses 1 sources. The price is not final yet.